NCT04989543View on ClinicalTrials.gov

Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s)

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

December 3, 2020

Study Completion Date

November 3, 2021

Conditions
Vaginosis, Bacterial
Interventions
DIAGNOSTIC_TEST

vaginal swabs

"Nugent score: Vaginal swabbing with the dry swab, make two smears on slides.~Cytobacteriological examination: swabbing at the exo-endocrine junction using the swab~Evaluation of the vaginal microbiota: swabbing at the exo-endocrine junction using the swab"

Trial Locations (1)

75014

Institut FOURNIER, Paris

Sponsors
All Listed Sponsors
collaborator

CEN Biotech

INDUSTRY

collaborator

Luxia Scientific

INDUSTRY

lead

Larena SAS

INDUSTRY

NCT04989543 - Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s) | Biotech Hunter | Biotech Hunter